The COVID-19 pandemic: a catalyst to improve clinical trials

The COVID-19 pandemic has provided the vital stepping stones to improve how clinical trials are conducted. We provide an overview of the major changes to the clinical trial process instigated by the pandemic and suggest ways to make these changes sustainable.

Detalles Bibliográficos
Autores principales: Gaba, Prakriti, Bhatt, Deepak L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461742/
https://www.ncbi.nlm.nih.gov/pubmed/32873977
http://dx.doi.org/10.1038/s41569-020-00439-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461742/
https://www.ncbi.nlm.nih.gov/pubmed/32873977
http://dx.doi.org/10.1038/s41569-020-00439-7

Ejemplares similares